New Delhi, Aug. 27 -- India aims to prevent potentially dangerous drug reactions before they reach patients, moving beyond largely retrospective reporting towards proactive drug-safety monitoring. Under a proposed national framework, healthcare professionals will record "near misses"-from risky drug combinations to allergies and dosing errors-so regulators can identify recurring risks and issue safety alerts, according to two government officials and a document reviewed by Mint.

The initiative, taken up by the Indian Pharmacopoeia Commission (IPC), under the health ministry, aims to systematically record instances where potential drug-drug interactions and critical patient allergies are intercepted by doctors, nurses, and clinical pharma...